User:Mr. Ibrahem/Olaparib

Olaparib, sold under the brand name Lynparza, is a medication used to treat ovarian cancer, fallopian tube cancer, and peritoneal cancer. It is used in cases that have failed other treatments and are likely BRCA mutation positive. It is taken by mouth.

Common side effects include tiredness, nausea, diarrhea, heartburn, cough, headache, shortness of breath, low white blood cells, and low platelets. Other side effects may include myelodysplastic syndrome and pneumonitis. It should not be used when breastfeeding or pregnant. It is a PARP inhibitor and works by blocking the ability of cancer cells to repair their DNA.

Olaparib was approved for medical use in Europe and the United States in 2014. In the United Kingdom a dose of 300 mg twice per day costs about £4,600 for 4 weeks as of 2021. This amount in the United States costs about 14,000 USD.